And maybe large institutional players? IMO....AVMXY will not last 5 years independently....Too many large pharma's looking to buy companies early in the game....
I'm expecting the BOD to exercise their fiduciary responsibilities by accepting any offer at a major premium if and when the time comes...When you look at the markets and indications this tech can penetrate and dominate, that number should be a minimum of 2-3 billion...imo
If you notice in the blackcrane analysis they mention another possible capital injection to hasten growth....
News 
Market Data 
Discover 
